Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology
Marinomed secures financing through successful capital increase
Marinomed Biotech Announces Capital increase with subscription rights
Public Relations